✦ LIBER ✦

Cost-Effectiveness of Telaprevir Plus Peginterferon/Ribavirin (TVR+PR) Versus Peginterferon/Ribavirin (PR) in Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients with F2 Fibrosis in Brazil

✍ Scribed by Morais, A.D.; Pereira, M.L.

Book ID: 122158957
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 60 KB
Volume: 16
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.08.185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of insulin resistance with met

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin

✍ Manuel Romero-Gómez; Moisés Diago; Raúl J. Andrade; José L. Calleja; Javier Salm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB 👁 1 views

Insulin resistance affects sustained virological response (SVR) in chronic hepatitis C. To know whether adding metformin to standard antiviral treatment improves SVR, we conducted a prospective, multicentered, randomized, double-blinded, placebo-controlled trial in 19 Spanish hospitals, including 12

PGI16 Cost Effectiveness of Boceprevir P

PGI16 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I Patients

✍ M. Fonseca; V. Garran; G.T. Araujo 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PGI25 Cost Effectiveness of Boceprevir P

PGI25 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I Patients

✍ M. Fonseca; G. Tannus; E. Parisi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PGI21 Cost Effectiveness of the Combinat

PGI21 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Retreatment of Patients With Chronic Hepatitis C Virus Genotype I Infection

✍ M. Fonseca; V. Garran; G.T. Araujo 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

1102 THE COST-EFFECTIVENESS OF TELAPREVI

1102 THE COST-EFFECTIVENESS OF TELAPREVIR (TVR) IN COMBINATION WITH PEGYLATED INTERFERON-ALFA AND RIBAVIRIN (PR) FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

✍ Curtis, S.; Cure, S.; Gavart, S.; Dearden, L.; Fleischmann, J.; Ouwens, M.; Lee, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Predictors of Sustained Virologic Respon

Predictors of Sustained Virologic Response Among Treatment-NaïVE Patients With Hepatitis C Virus Genotype 1 When Treated With Boceprevir (Boc) Plus Peginterferon Alfa-2B-Ribavirin (PR)

✍ Reddy, Rajender ;Bruno, Savino ;Rossaro, Lorenzo ;Ravendhran, Natarajan ;Pauly, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 439 KB